Ize-Ludlow Diego, Gray Juliette A, Sperling Mark A, Berry-Kravis Elizabeth M, Milunsky Jeff M, Farooqi I Sadaf, Rand Casey M, Weese-Mayer Debra E
Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Pediatrics. 2007 Jul;120(1):e179-88. doi: 10.1542/peds.2006-3324.
The goal was to characterize the phenotype and potential candidate genes responsible for the syndrome of late-onset central hypoventilation with hypothalamic dysfunction.
Individuals with late-onset central hypoventilation with hypothalamic dysfunction who were referred to Rush University Medical Center for clinical or genetic assessment in the past 3 years were identified, and medical charts were reviewed to determine shared characteristics of the affected subjects. Blood was collected for genetic testing of candidate genes (PHOX2B, TRKB, and BDNF) and for high-resolution conventional G-banding, subtelomeric fluorescent in situ hybridization, and comparative genomic hybridization analysis. A subset of these children were studied in the Pediatric Respiratory Physiology Laboratory at Rush University Medical Center.
Twenty-three children with what we are now naming rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation were identified. Comprehensive medical charts and blood for genetic testing were available for 15 children; respiratory physiology studies were performed at Rush University Medical Center on 9 children. The most characteristic manifestations were the presentation of rapid-onset obesity in the first 10 years of life (median age at onset: 3 years), followed by hypothalamic dysfunction and then onset of symptoms of autonomic dysregulation (median age at onset: 3.6 years) with later onset of alveolar hypoventilation (median age at onset: 6.2 years). Testing of candidate genes (PHOX2B, TRKB, and BDNF) revealed no mutations or rare variants. High-resolution chromosome analysis, comparative genomic hybridization, and subtelomeric fluorescent in situ hybridization results were negative for the 2 patients selected for those analyses.
We provide a comprehensive description of the clinical spectrum of rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation in terms of timing and scope of symptoms, study of candidate genes, and screening for chromosomal deletions and duplications. Negative PHOX2B sequencing results demonstrate that this entity is distinct from congenital central hypoventilation syndrome.
本研究旨在明确导致迟发性中枢性通气不足伴下丘脑功能障碍综合征的表型及潜在候选基因。
确定过去3年转诊至拉什大学医学中心进行临床或基因评估的迟发性中枢性通气不足伴下丘脑功能障碍患者,并查阅病历以确定受影响患者的共同特征。采集血液用于候选基因(PHOX2B、TRKB和BDNF)的基因检测以及高分辨率常规G显带、亚端粒荧光原位杂交和比较基因组杂交分析。这些儿童中的一部分在拉什大学医学中心的儿科呼吸生理学实验室进行了研究。
共确定了23例患有我们现在命名为快速发作性肥胖伴下丘脑功能障碍、通气不足和自主神经失调的儿童。15例儿童有完整的病历和用于基因检测的血液样本;9例儿童在拉什大学医学中心进行了呼吸生理学研究。最典型的表现是在生命的前10年出现快速发作性肥胖(发病中位年龄:3岁),随后是下丘脑功能障碍,然后出现自主神经失调症状(发病中位年龄:3.6岁),肺泡通气不足出现较晚(发病中位年龄:6.2岁)。候选基因(PHOX2B、TRKB和BDNF)检测未发现突变或罕见变异。所选2例患者的高分辨率染色体分析、比较基因组杂交和亚端粒荧光原位杂交结果均为阴性。
我们从症状出现的时间和范围、候选基因研究以及染色体缺失和重复筛查等方面,对快速发作性肥胖伴下丘脑功能障碍、通气不足和自主神经失调的临床谱进行了全面描述。PHOX₂B测序结果为阴性,表明该疾病与先天性中枢性通气不足综合征不同。